Beyond the NGS Report: Practical Interpretation for Lung Cancer Care

Prof Stephen Fox

Director of Pathology and Group Leader, Peter MacCallum Cancer Centre
Deputy Director, Collaborative Centre for Genomic Cancer Medicine, University of Melbourne

Stephen Fox is Director of Pathology at the Peter MacCallum Cancer Centre and Professorial Fellow at the University of Melbourne. He holds Honours degree and Medical degrees from the University of Bristol, UK and a DPhil in Medicine from the University of Oxford. He has Fellowships of both the Royal College of Pathologists Australasia (RCPA) and UK and is also a Founding Fellow of the Faculty of Science. He is an NHMRC Leadership Fellow and a Fellow of the Australian Academy of Health and Medical Sciences. He is an expert member of the WHO Classification of Breast Tumours and has a research interest in diagnostic and predictive markers in breast and other tumour types using protein and nucleic acid-based assays.

A/Prof Caroline Cooper

Anatomical Pathologist
Pathology Queensland, Princess Alexandra Hospital

A/Prof Cooper BMedSci, MB, BS (Hons), FRCPA, GCertHE, MPhil is a Senior Anatomical Pathologist and Co-Medical Director, working for Pathology Queensland at Princess Alexandra Hospital (PAH), Brisbane, Queensland. She graduated in medicine from the University of Tasmania and undertook specialist Anatomical Pathology training at Westmead and Royal Prince Alfred Hospitals in Sydney.

A/Prof Cooper is President-Elect of the Australasian Division of the International Academy of Pathology and Director of the International Collaboration on Cancer Reporting.

A/Prof Cooper has a special interest in Pulmonary, Gastrointestinal and Head and Neck pathology. Her research focuses on biomarkers in cancer, including prediction of response to immune checkpoint inhibitors. 

Dr Jennifer Borowsky

Anatomical and Molecular Pathologist
Pathology Queensland, Princess Alexandra Hospital

Jennifer Borowsky, MBChB, PhD, FRCPA, graduated with a Bachelor of Medicine and Surgery in 2008 and was awarded Fellowship of the Royal Australasian College of Pathologists in Anatomical Pathology in 2016. She completed a fellowship in Gastrointestinal and Liver Pathology at Massachusetts General Hospital and Dana Farber Cancer Institute in Boston in 2017. She concurrently commenced and has completed a PhD in the molecular pathobiology of colorectal cancer and continues to publish in this field through appointments to the Conjoint Gastroenterology Group at the Queensland Institute of Medical Research (QIMR) and national and international collaborations. Jennifer is a Senior Pathologist and co-director of Anatomical Pathology at the Princess Alexandra Hospital as well as Molecular Pathologist at the Royal Brisbane Hospital overseeing molecular sequencing of solid tumours.

A/Prof Malinda Itchins

Medical Oncologist
Royal North Shore Hospital and Chris O'Brien Lifehouse

A/Prof Malinda Itchins BMedSci, MBBS(Hons1), FRACP, PhD, is a thoracic medical oncologist at Royal North Shore Hospital, and Chris O'Brien Lifehouse, Sydney. She is a senior clinical lecturer with the University of Sydney and Board Director with the Clinical Oncology Society of Australia (COSA). Malinda is Co-Chair of the Advanced NSCLC Group on the Scientific Committee of the Thoracic Oncology Group of Australasia (TOGA), and passionate trialist, researcher and advocate for improving care for all people affected by lung cancer.

Dr Lavinia Tan

Medical Oncologist
Peter MacCallum Cancer Centre

Dr Lavinia Tan is a Medical Oncologist with a sub-speciality interest in treating patients with lung cancer. She completed a clinical fellowship focusing on thoracic malignancies at the Peter MacCallum Cancer Centre and a laboratory-based PhD exploring the utility of circulating tumour DNA to guide precision medicine in solid malignancies. Lavinia’s main research interests focus on understanding how lung cancers evolve and developing novel strategies to overcome resistance to targeted therapies in oncogene driven lung cancers.